Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamad Navab

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Future Cardiology|October 7, 2009
Oxidation hypothesis of atherogenesis: HDL inflammatory index and apolipoprotein A-I mimetic peptidesRoger Yu, Mohamad Navab
International Journal of Hypertension|April 21, 2012
Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout MiceKazunobu Ishikawa, Mohamad Navab, Aldons J Lusis
Current Opinion in Clinical Nutrition and Metabolic Care|June 11, 2008
Inflammation and metabolic disordersMohamad Navab, Nima Gharavi, Andrew D Watson
Circulation Research|November 25, 2005
An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-IMohamad Navab, G M Anantharamaiah, Alan M Fogelman
Circulation Research|December 7, 2013
Protection against ischemia/reperfusion injury by high-density lipoprotein and its componentsAlan M Fogelman, Srinivasa T Reddy, Mohamad Navab
Nature Reviews. Nephrology|March 24, 2010
HDL metabolism and activity in chronic kidney diseaseNosratola D Vaziri, Mohamad Navab, Alan M Fogelman
Trends in Cardiovascular Medicine|March 1, 2008
The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosisMohamad Navab, G M Anantharamaiah, Alan M Fogelman
Trends in Cardiovascular Medicine|August 16, 2005
The role of high-density lipoprotein in inflammationMohamad Navab, G M Anantharamaiah, Alan M Fogelman
Stroke|January 27, 2007
High-density lipoprotein cholesterol: an emerging target for stroke treatmentNerses Sanossian, Jeffrey L Saver, Mohamad Navab, et al.
Circulation|September 25, 2003
Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null miceMohamad Navab, Susan Hama, Greg Hough, et al.
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Future Cardiology|October 7, 2009
Oxidation hypothesis of atherogenesis: HDL inflammatory index and apolipoprotein A-I mimetic peptidesRoger Yu, Mohamad Navab
International Journal of Hypertension|April 21, 2012
Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout MiceKazunobu Ishikawa, Mohamad Navab, Aldons J Lusis
Current Opinion in Clinical Nutrition and Metabolic Care|June 11, 2008
Inflammation and metabolic disordersMohamad Navab, Nima Gharavi, Andrew D Watson
Circulation Research|November 25, 2005
An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-IMohamad Navab, G M Anantharamaiah, Alan M Fogelman
Circulation Research|December 7, 2013
Protection against ischemia/reperfusion injury by high-density lipoprotein and its componentsAlan M Fogelman, Srinivasa T Reddy, Mohamad Navab
Nature Reviews. Nephrology|March 24, 2010
HDL metabolism and activity in chronic kidney diseaseNosratola D Vaziri, Mohamad Navab, Alan M Fogelman
Trends in Cardiovascular Medicine|March 1, 2008
The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosisMohamad Navab, G M Anantharamaiah, Alan M Fogelman
Trends in Cardiovascular Medicine|August 16, 2005
The role of high-density lipoprotein in inflammationMohamad Navab, G M Anantharamaiah, Alan M Fogelman
Stroke|January 27, 2007
High-density lipoprotein cholesterol: an emerging target for stroke treatmentNerses Sanossian, Jeffrey L Saver, Mohamad Navab, et al.
Circulation|September 25, 2003
Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null miceMohamad Navab, Susan Hama, Greg Hough, et al.
Pageof 15